Ellie Eunkyung Im
Ellie Eunkyung Im's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2026
Ellie Eunkyung Im has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Ellie Eunkyung Im reported 0 open-market purchases and 2 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Ellie Eunkyung Im's trades
Has Ellie Eunkyung Im bought shares on the open market?
Ellie Eunkyung Im has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
When did Ellie Eunkyung Im last buy or sell shares?
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Which companies has Ellie Eunkyung Im traded as an insider?
Crescent Biopharma (CBIO), from 2026 to 2026: 0 purchases and 2 sales.